We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-0.47%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.27B
AUM Growth
-$622M
Cap. Flow
-$458M
Cap. Flow %
-10.71%
Top 10 Hldgs %
7.07%
Holding
1,383
New
78
Increased
507
Reduced
362
Closed
118

Top Buys

Rank Stock Value
1
DNOW icon
DNOW Inc
DNOW
+$10.8M
2
VTLE
Vital Energy
VTLE
+$9.28M
3
HTH icon
Hilltop Holdings
HTH
+$7.5M
4
PSFE icon
Paysafe
PSFE
+$7.41M
5
PINC
Premier
PINC
+$7.18M

Sector Composition

Rank Sector Weight
1 Financials 27.03%
2 Industrials 13.12%
3 Consumer Discretionary 12.97%
4 Technology 10.69%
5 Energy 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLUE
1001
DELISTED
bluebird bio
BLUE
$251K 0.01%
12,750
+2,750
+28% +$55.1K
IRD
1002
Opus Genetics
IRD
$307M
$251K 0.01%
163,741
-46,200
-22% -$79.9K
MU icon
1003
Micron Technology
MU
$996B
$250K 0.01%
1,900
GDEN
1004
DELISTED
Golden Entertainment
GDEN
$249K 0.01%
8,018
+540
+7% +$17.2K
TELA icon
1005
TELA Bio
TELA
$38.5M
$249K 0.01%
53,000
+16,000
+43% +$84.3K
ARMP icon
1006
Armata Pharmaceuticals
ARMP
$173M
$249K 0.01%
90,382
-20,000
-18% -$57.1K
AMPX icon
1007
Amprius Technologies
AMPX
$1.58B
$248K 0.01%
+195,000
New +$318K
KRON
1008
DELISTED
Kronos Bio
KRON
$248K 0.01%
199,702
-115,300
-37% -$117K
AMLX icon
1009
Amylyx Pharmaceuticals
AMLX
$2.69B
$247K 0.01%
+130,000
New +$252K
OMGA
1010
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$246K 0.01%
119,000
-25,000
-17% -$58.9K
SNCR
1011
DELISTED
Synchronoss Technologies
SNCR
$244K 0.01%
26,219
-14,316
-35% -$116K
BLZE icon
1012
Backblaze
BLZE
$1.12B
$243K 0.01%
39,500
SHCR
1013
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$242K 0.01%
+179,300
New +$147K
SPRO icon
1014
Spero Therapeutics
SPRO
$73.5M
$240K 0.01%
184,800
BLND icon
1015
Blend Labs
BLND
$472M
$239K 0.01%
101,300
LVLU icon
1016
Lulu's Fashion Lounge
LVLU
$49.7M
$237K 0.01%
8,527
EXFY icon
1017
Expensify
EXFY
$191M
$235K 0.01%
158,000
-50,000
-24% -$78.8K
PRCH icon
1018
Porch Group
PRCH
$1.75B
$234K 0.01%
155,233
SVT
1019
DELISTED
Servotronics
SVT
$234K 0.01%
19,653
SCWX
1020
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$232K 0.01%
33,180
-10,000
-23% -$61.4K
BRID icon
1021
Bridgford Foods
BRID
$57.1M
$232K 0.01%
23,100
BCIC
1022
BCP Investment Corp
BCIC
$91.5M
$232K 0.01%
11,820
CRVS icon
1023
Corvus Pharmaceuticals
CRVS
$1.17B
$232K 0.01%
127,300
-97,000
-43% -$181K
ACET icon
1024
Adicet Bio
ACET
$74.1M
$231K 0.01%
11,956
+3,843
+47% +$103K
RJET
1025
Republic Airways Holdings
RJET
$996M
$231K 0.01%
9,000
-8,040
-47% -$132K

Similar funds

Bridgeway Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Bridgeway Capital Management held 1,383 positions worth $4.27B, down 13% from $4.89B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.

Bridgeway Capital Management withdrew a net $458M in Q2 2024, closing 118 positions and reducing 362 holdings. Its most notable exit was Netflix, an estimated $7.59M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Bridgeway Capital Management opened a new position in DNOW Inc worth $10.4M.

  • Bridgeway Capital Management's largest Q2 2024 buy was DNOW Inc: 758,458 shares worth $10.4M.
  • Bridgeway Capital Management added most to Vital Energy in Q2 2024, an estimated $9.28M increase.
  • Bridgeway Capital Management's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $17.7M.
  • Bridgeway Capital Management fully exited Netflix in Q2 2024, selling an estimated $7.59M.
  • Bridgeway Capital Management's ten largest holdings make up 7.1% of its $4.27B portfolio in Q2 2024.
  • Bridgeway Capital Management opened 78 new positions and closed 118 in Q2 2024.
  • Bridgeway Capital Management's portfolio value fell 13% quarter-over-quarter to $4.27B.

Based on Bridgeway Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.